Timoptol



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 23.7%
Glaucoma 21.1%
Asthma 10.5%
Hypertension 10.5%
Intraocular Pressure Increased 5.3%
Intraocular Pressure Test Abnormal 5.3%
Type 2 Diabetes Mellitus 5.3%
Anticoagulant Therapy 2.6%
Epilepsy 2.6%
Fungal Infection 2.6%
Headache 2.6%
Hypercholesterolaemia 2.6%
Hypertensive Cardiomyopathy 2.6%
Hyperthyroidism 2.6%
Cerebral Vasoconstriction 15.0%
Atrial Fibrillation 10.0%
Somnolence 10.0%
Wound 10.0%
Adverse Event 5.0%
Anosmia 5.0%
Blindness Unilateral 5.0%
Drug Dose Omission 5.0%
Insomnia 5.0%
Intraocular Pressure Increased 5.0%
Sexual Dysfunction 5.0%
Sjogren's Syndrome 5.0%
Sternal Fracture 5.0%
Therapy Cessation 5.0%
Xerosis 5.0%
Secondary
Glaucoma 37.2%
Drug Use For Unknown Indication 18.6%
Cataract 9.3%
Intraocular Pressure Increased 7.0%
Product Used For Unknown Indication 7.0%
Fungal Infection 4.7%
Hypertension 4.7%
Ocular Hypertension 4.7%
Arrhythmia 2.3%
Major Depression 2.3%
Normal Tension Glaucoma 2.3%
Off Label Use 27.8%
Intraocular Pressure Decreased 11.1%
Sjogren's Syndrome 11.1%
Vitreous Disorder 11.1%
Anosmia 5.6%
Atrioventricular Block 5.6%
Corneal Oedema 5.6%
Malaise 5.6%
Ocular Hyperaemia 5.6%
Somnolence 5.6%
Visual Acuity Reduced 5.6%
Concomitant
Glaucoma 18.0%
Behcet's Syndrome 12.7%
Prophylaxis 12.1%
Product Used For Unknown Indication 8.5%
Hypertension 6.1%
Ocular Hypertension 4.7%
Castleman's Disease 3.8%
Cataract 3.4%
Drug Use For Unknown Indication 3.2%
Keratitis 3.2%
Sinusitis 3.2%
Cancer Pain 3.0%
Diabetes Mellitus 3.0%
Osteoporosis 3.0%
Constipation 2.5%
Thrombosis Prophylaxis 2.3%
Arthritis 1.9%
Depression 1.9%
Gastritis 1.9%
Insomnia 1.9%
Intraocular Pressure Increased 11.1%
Visual Acuity Reduced 7.9%
Asthma 6.3%
Cataract 6.3%
Drug Ineffective 6.3%
Pelvic Mass 6.3%
Visual Impairment 6.3%
Glaucoma 4.8%
Pyrexia 4.8%
Urinary Tract Infection 4.8%
Vomiting 4.8%
White Blood Cell Count Decreased 4.8%
Cerebral Haemorrhage 3.2%
Convulsion 3.2%
Dehydration 3.2%
Epilepsy 3.2%
Hypotension 3.2%
Infusion Related Reaction 3.2%
Injury 3.2%
Interstitial Lung Disease 3.2%